RE:RE:RE:RE: "excellent" progress on early-stage pipelineDenali Therapeutics who BTI management has compared us to in the past gained 50% ruffly last week when they annouced their quarter, $23 to a high of $36 the next day. It carries a $3.5 Billion market cap today with pitance revenues of $5.85 million and no drugs approved from what I can read into things.
All the while with less advantageous technology while we sit at $20 million market cap,,,,,,,,,,,,,,,a vast ways to move up in share price when the market understands the comparison.
We would be at $52 a share to mirrow their market cap!!!,,,,Look out above!!!!!